- Home
- ESPR vs GCL Comparison
ESPR vs GCL Comparison
Compare ESPR & GCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- GCL
- Stock Information
- Founded
- ESPR 2008
- GCL 2011
- Country
- ESPR United States
- GCL Singapore
- Employees
- ESPR N/A
- GCL N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- GCL
- Sector
- ESPR Health Care
- GCL
- Exchange
- ESPR Nasdaq
- GCL NYSE
- Market Cap
- ESPR 305.0M
- GCL 250.7M
- IPO Year
- ESPR 2013
- GCL N/A
- Fundamental
- Price
- ESPR $0.80
- GCL $2.27
- Analyst Decision
- ESPR Buy
- GCL
- Analyst Count
- ESPR 7
- GCL 0
- Target Price
- ESPR $5.93
- GCL N/A
- AVG Volume (30 Days)
- ESPR 5.1M
- GCL 44.4K
- Earning Date
- ESPR 05-06-2025
- GCL 01-01-0001
- Dividend Yield
- ESPR N/A
- GCL N/A
- EPS Growth
- ESPR N/A
- GCL N/A
- EPS
- ESPR N/A
- GCL N/A
- Revenue
- ESPR $259,574,000.00
- GCL $112,351,837.00
- Revenue This Year
- ESPR $5.70
- GCL N/A
- Revenue Next Year
- ESPR N/A
- GCL N/A
- P/E Ratio
- ESPR N/A
- GCL N/A
- Revenue Growth
- ESPR 12.99
- GCL 25.23
- 52 Week Low
- ESPR $0.82
- GCL $1.76
- 52 Week High
- ESPR $3.94
- GCL $15.55
- Technical
- Relative Strength Index (RSI)
- ESPR 32.43
- GCL N/A
- Support Level
- ESPR $0.93
- GCL N/A
- Resistance Level
- ESPR $1.11
- GCL N/A
- Average True Range (ATR)
- ESPR 0.11
- GCL 0.00
- MACD
- ESPR 0.01
- GCL 0.00
- Stochastic Oscillator
- ESPR 17.93
- GCL 0.00
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About GCL GCL GLOBAL HOLDINGS LTD
GCL Global Holdings Ltd is a provider of games and entertainment content based in Asia. The company unites people through games and entertainment experiences, enabling creators to deliver engaging content and fun gameplay experiences to the gaming communities across the globe, with a strategic focus on the rapidly expanding Asian gaming market. Its mission is to bridge cultures and audiences by introducing Asian-developed IP to a multinational audience across consoles, PCs and streaming platforms.